top of page

We have a proven track record of success
The efficacy of ultra-large virtual screening is validated in 5+ publications, including in Nature
Past Target Screens and Awards

Small Title
Target: SARS-CoV2
Indication: COVID-19
Results:
-
17 proteins, 40 target sites
-
Screened 1 billion for each
-
nanomolar hits
-
cellular activity

Small Title
Target: KEAP1-NRF2
Indication: Multiple Indications
Results:
-
Screened 1.3billion compounds
-
PPI (protein-protein interaction)
-
Best compound: 9nM Kd
-
Nature 2020

Small Title
Award: Recipient of the 2020 HPC Readers and Editors' Choice award
Past Clients

Academic Labs at Top 20 US Universities

Private companies in the biotech, agritech, & biopharma industries

Boston-based start-ups, and start-ups from across the US

International (Europe, Middle East, etc.) early-stage companies and academic labs
bottom of page